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Abstract
In the paper by Dieguez-Gonzalez and colleagues in the present
issue of Arthritis Research & Therapy, the results of a detailed
genetic investigation of the recently identified rheumatoid arthritis
and systemic lupus erythematosus susceptibility region at 6q23
containing the TNFAIP3 gene are reported. Their data confirm the
complex nature of the association involving both the TNFAIP3
locus and a region >150 kb upstream that does not encode any
known gene. These data are consistent with recent studies of
systemic lupus erythematosus susceptibility confirming the
presence of several independent genetic contributions to auto-
immune rheumatic diseases arising from 6q23.
In the present issue of Arthritis Research & Therapy,
Dieguez-Gonzalez and colleagues report the results of a large
case–control genetic study of the 6q23 region that contains
the TNFAIP3 gene [1]. Their study reveals a complex asso-
ciation involving interactions between the TNFAIP3 locus and
an intergenic region >150 kb upstream.
The upstream region was initially implicated in rheumatoid
arthritis (RA) susceptibility in the Wellcome Trust Case
Control Consortium study [2], and was subsequently
replicated in large European and American populations [3,4].
The biological explanation was not clear as the associated
SNPs (rs6920220 and rs10499194) are located in a 60 kb
linkage disequilibrium block not encoding any known genes
or transcripts other than a pseudogene of PTPN11. The
region is flanked by the OLIG3 and TNFAIP3 loci. The former
encodes a protein involved in neuronal development and
does not seem to be a plausible susceptibility gene for RA;
however, the TNFAIP3 gene encodes a potent inhibitor of
NF-κB signalling, resulting in downregulation of production of
proinflammatory cytokines including TNF, IL-1 and IL-6, and
mice with targeted deletion of TNFAIP3 develop cachexia
widespread organ inflammation, including a destructive
arthritis [5]. Additional loci encoding immune relevant
proteins (IL22RA and IFNGR1) are also located within 1 Mb.
Recent genetic studies of 6q23 in systemic lupus erythe-
matosus (SLE) have revealed a more complex pattern of
associations than was initially reported for RA. A genome
scan reported three independent associations arising from
the upstream region (rs6920220) and two signals near the
TNFAIP3 gene including a missense polymorphism in exon 3
(rs2230926), resulting in a phenylalanine to cysteine switch
at amino acid 127 of TNFAIP3 [6]. These findings have been
replicated in a case–control study that typed 129 SNPs
spanning TNFAIP3; furthermore, examination of the functional
effects of the lupus-associated Cys127 variant revealed
reduced effectiveness at inhibiting TNF-induced NF-κB
activity, suggesting a biological mechanism of association [7].
The study by Dieguez-Gonzalez and colleagues involved the
use of haplotype tagging SNPs centred on two regions
identified in the SLE studies. Surprisingly, only modest
associations with RA were detected at both the TNFAIP3
and intergenic regions. This is a common finding in replication
studies reflecting winner curse. On further analysis, however,
strong evidence of interaction (epistasis) between the two
regions with RA susceptibility was detected.
We can therefore conclude that the 6q23 region contains at
least two RA susceptibility effects and perhaps three effects
for SLE. The biological mechanism for the associations of the
intergenic region is unclear since it is only known to contain
the pseudogene for PTPN11. Intriguingly, however, the
parent PTPN11 gene – located at 12q24.13 – lies within a
region associated with susceptibility to RA, type 1 diabetes
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and inflammatory bowel disease [2]. Approximately 20% of
pseudogenes are transcribed, and some generate siRNAs
that target homologous genes [8]. Sequence variability in the
sequence of the pseudogene could potentially affect expres-
sion of PTPN11, leading to autoimmune disease. Determining
whether the pseudogene is transcribed and whether
sequence variants of the transcript are present on disease-
associated haplotypes will therefore be required as initial
steps in determining its potential role in modulating PTPN11
expression. An alternative explanation is that a polymorphism
within an enhancer sequence in the intergenic region may
alter  TNFAIP3 expression. The most plausible disease
susceptibility variant identified so far is rs2230926, with
experimental evidence that the SLE-associated variant is less
biologically active [6].
The identification of the primary disease-related variants at
6q23 is likely to initially involve high-throughput DNA
sequencing in a large number of patients and controls to
more fully characterise the genetic structure of the region.
This will be followed by well-powered genetic studies in both
RA and SLE that will hopefully lead to the identification of the
primary disease-related variants, some of which may arise
from low-frequency alleles. Complementary functional studies
should lead to a full understanding of the biological basis of
the genetic associations of this region with autoimmune
rheumatic diseases.
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